
A panel of experts open a discussion surrounding the current disease landscape of HIV.
A panel of experts open a discussion surrounding the current disease landscape of HIV.
Payor considerations in the treatment of HIV are explored.
Dr Adam C. Welch drives a discussion highlighting disparities in health care equity affecting patients who receive an HIV diagnosis.
An expert panel navigates stigmas and barriers inhibiting patients from achieving optimal care for HIV.
Key opinion leaders discuss the influence of guideline-directed therapy in the treatment of patients with HIV.
The treatment landscape for HIV is discussed by a panel led by Dr Welch.
The role of and indication for long-acting injectables is highlighted as a treatment approach for HIV.
Medical experts discuss the significance of pill burden in the HIV treatment pathway.
Assessing the quality of an HIV treatment plan is crucial to patient prognosis.
Key opinion leaders discuss the value of real-world evidence in the management of HIV.
Dr Welch leads a discussion on collaborations between payers, patients, and providers to optimize the care of patients with HIV.
The panel discusses unmet needs that remain in the treatment and management of HIV.
The panel of experts discusses emerging and anticipated changes to the HIV treatment landscape.
Panelists provide their closing thoughts on optimizing the management of HIV.
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.